In the takeover battle of the year, target Virtus Health has recommended BGH Capital’s latest bid, three days after the IVF provider invoked an “out provision” in its sale deal with a rival bidder, the UK-based private equity firm CapVest Partners.
Virtus also said an updated independent expert report found that the CapVest scheme was not in the best interests of Virtus shareholders given the revised BGH unconditional offer.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
